{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T07:08:48Z","timestamp":1781939328841,"version":"3.54.5"},"reference-count":5,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T00:00:00Z","timestamp":1695254400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.jdcr.2023.09.006","type":"journal-article","created":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T21:40:17Z","timestamp":1695764417000},"page":"31-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Incidental improvement of programmed cell death-1 receptor inhibitor-induced vitiligo after initiation of dupilumab therapy for refractory pruritus"],"prefix":"10.1016","volume":"42","author":[{"given":"Warner","family":"Robinson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth N.","family":"McLellan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdcr.2023.09.006_bib1","series-title":"Unmasking of a TH1-mediated vitiligo-like tendency in the setting of dupilumab therapy for adult atopic dermatitis","author":"Magro","year":"2020"},{"issue":"10","key":"10.1016\/j.jdcr.2023.09.006_bib2","doi-asserted-by":"crossref","DOI":"10.2340\/actadv.v101.545","article-title":"Rapid enlargement of vitiligo vulgaris after initiation of dupilumab for atopic dermatitis: a case report","volume":"101","author":"Takeoka","year":"2021","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jdcr.2023.09.006_bib3","doi-asserted-by":"crossref","first-page":"829","DOI":"10.2147\/CCID.S364243","article-title":"Skin manifestation induced by immune checkpoint inhibitors","volume":"15","author":"Yamamoto","year":"2022","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"10.1016\/j.jdcr.2023.09.006_bib4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jdcr.2023.03.025","article-title":"Vitiligo during dupilumab therapy","volume":"36","author":"Picone","year":"2023","journal-title":"JAAD Case Rep"},{"issue":"8","key":"10.1016\/j.jdcr.2023.09.006_bib6","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/exd.14129","article-title":"Understanding the significance of cytokines and chemokines in the pathogenesis of alopecia areata","volume":"29","author":"Ito","year":"2020","journal-title":"Exp Dermatol"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512623003533?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512623003533?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:25:54Z","timestamp":1762475154000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512623003533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":5,"alternative-id":["S2352512623003533"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2023.09.006","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidental improvement of programmed cell death-1 receptor inhibitor-induced vitiligo after initiation of dupilumab therapy for refractory pruritus","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2023.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc. on behalf of the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}